Press Releases

11/4/2009 Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results	8.4 KB
10/30/2009 Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering	8.0 KB
8/11/2009 Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain	10.6 KB
8/11/2009 Javelin Pharmaceuticals, Inc. Reports Second Quarter 2009 Results and Corporate Highlights	15.3 KB
8/4/2009 Javelin Pharmaceuticals to Host Second Quarter 2009 Conference Call	8.4 KB
6/23/2009 Javelin Pharmaceuticals Completes Open Label Safety Study of Dyloject(TM) -	10.4 KB
6/15/2009 New Study Shows Javelin Pharmaceutical's DylojectTM Well-Tolerated in High-Risk Patients with Impaired Renal and Hepatic Function	9.4 KB
5/7/2009 Javelin Pharmaceuticals, Inc. Reports First Quarter 2009 Results and Corporate Highlights	14.0 KB
5/4/2009 Javelin Pharmaceuticals to Announce First Quarter 2009 Financial Results	8.3 KB
3/12/2009 Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2008	14.1 KB
3/5/2009 Javelin Pharmaceuticals Quarterly Conference Call Invitation	8.3 KB
1/15/2009 Javelin Pharmaceuticals Signs $71 million European Commercialization Partnership for Dyloject(R)	10.0 KB
1/8/2009 Javelin Pharmaceuticals CEO Martin J. Driscoll to Present at J.P. Morgan's 27th Annual Healthcare Conference	8.1 KB
12/9/2008 Dyloject(TM) Significantly Reduces Moderate-to-Severe Pain in Pivotal Phase 3 Orthopedic Surgical Trial	12.0 KB
11/14/2008 Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce	8.7 KB
11/10/2008 Javelin Pharmaceuticals, Inc. Reports Third Quarter 2008 Results and Corporate Highlights	11.7 KB
11/6/2008 Javelin Pharmaceuticals to Review Third Quarter 2008 Financial Results	7.7 KB
10/20/2008 Javelin Pharmaceuticals Appoints Dr. Eric Lang Vice President of Clinical Research	10.1 KB
9/22/2008 Javelin Enrolls First Patient in an Open Label Safety Study of Dyloject(TM)	10.6 KB
9/17/2008 Javelin Pharmaceuticals to Present at the 2008 UBS Global Life Sciences Conference	8.2 KB
Showing 21-40 of 156 releases Page: 1 2 3 4 5 6 7 8  See Previous 20 | See Next 20

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.